To evaluate the feasibility and short-term safety of peripheral retinal visualization using an intraocular endoscope-holding robot (OQrimo) without scleral depression during vitrectomy, compared with conventional methods. … [Read more...] about Robot-Assisted Peripheral Retinal Visualization During Vitrectomy Without Scleral Depression: A First-in-Human Comparative Study
News
OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment (FAST) Uveitis Trial
To evaluate optical coherence tomography vitreous signal intensity (OCT-VI) as a biomarker of vitreous haze in a longitudinal, prospective, and standardized manner in the First-Line Antimetabolites as Steroid-Sparing Treatment (FAST) Uveitis Trial. … [Read more...] about OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment (FAST) Uveitis Trial
Erratum to Retinitis Pigmentosa GTPase regulator–Associated Retinal Degeneration: Integrating Patient-Reported Outcomes, Genetic, and Structural Biomarkers
Omidenepag isopropyl may increase myopia in glaucoma
Omidenepag isopropyl eye drops may increase nearsightedness in patients with glaucoma, leading to myopic shifts of 0.75 D or more, according to a study published in Journal of Glaucoma.“Omidenepag isopropyl is a relatively new glaucoma medication that works differently from traditional prostaglandin analogs,” study author Jin-Soo Kim, MD, associate professor in the department … [Read more...] about Omidenepag isopropyl may increase myopia in glaucoma
A Future Treatment for Adult Amblyopia May Involve Retinal Inactivation Plus Thalamic Burst Firing
Results from a murine study suggest that the combination of temporary retinal inactivation and thalamic burst firing could aid in restoring vision loss due to amblyopia. … [Read more...] about A Future Treatment for Adult Amblyopia May Involve Retinal Inactivation Plus Thalamic Burst Firing